Lens implant may become a good alternative treatment for myopia

Jim Marino — Thu, 16 Jul 2009 07:47:33 +0000

An intraocular lens can correct myopia within 0.5 D of the target in 79% of eyes and caused no vision-threatening complications. This was reported by Japanese investigators from the University of Kitasato in the July issue of Archives of Ophthalmology. “Our long-term results indicate that [implantable collamer lens (ICL)] implantation is safe and effective and provides predictable and stable refractive results in the correction of moderate to high myopia throughout a four-year observation,” the authors said. These findings suggest that ICL implantation may be a good alternative for the treatment of moderate to high myopia.

China clears STAAR Visian Toric Implantable Collamer Lens

Jim Marino — Mon, 03 Mar 2008 19:41:20 +0000

STAAR Surgical Company has received approval from the Sate Food and Drug Administration (SFDA) of the People’s Republic of China to market its Visian™ Toric Implantable Collamer Lens (ICL) in the country for treating nearsightedness and astigmatism. This lens, made of a highly biocompatible material called Collamer, is minimally invasive and foldable. The ICL procedure makes an incision that is as much as 50% smaller than that made by other technologies and the lens is placed behind the iris.

Optometry Product Guide » ICL

Lens implant may become a good alternative treatment for myopia

China clears STAAR Visian Toric Implantable Collamer Lens